Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (31-40 of 326) with videos related to

Pageof 33
Sort By:
Journal of Gastroenterology and Hepatology|December 31, 2013
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatmentJames Fung, Wai-Kay Seto, Ching-Lung Lai, et al.
Expert Review of Clinical Pharmacology|January 10, 2019
Novel developments of hepatitis B: treatment goals, agents and monitoring toolsLung-Yi Mak, Wai-Kay Seto, James Fung, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2011
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Liver Cancer|December 24, 2021
Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular CarcinomaKa Shing Cheung, Lok Ka Lam, Wai Kay Seto, et al.
Expert Opinion on Drug Safety|January 12, 2016
DNA polymerase inhibitors for treating hepatitis B: a safety evaluationLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Gut and Liver|April 27, 2016
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionRan Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, et al.
Hepatology International|January 8, 2016
Prevention and management of hepatitis B virus reactivation in cancer patientsKa-Shing Cheung, Wai-Kay Seto, Ching-Lung Lai, et al.
Clinical and Molecular Hepatology|November 10, 2022
Correspondence on Letter regarding "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis"Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, et al.
Current Hepatitis Reports|December 2, 2011
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and SafetyYuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 15, 2017
Pharmacokinetic evaluation of besifovir for the treatment of HBV infectionLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Pageof 33

Showing results (31-40 of 326) with videos related to

Sort By:
Pageof 33
Journal of Gastroenterology and Hepatology|December 31, 2013
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatmentJames Fung, Wai-Kay Seto, Ching-Lung Lai, et al.
Expert Review of Clinical Pharmacology|January 10, 2019
Novel developments of hepatitis B: treatment goals, agents and monitoring toolsLung-Yi Mak, Wai-Kay Seto, James Fung, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2011
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Liver Cancer|December 24, 2021
Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular CarcinomaKa Shing Cheung, Lok Ka Lam, Wai Kay Seto, et al.
Expert Opinion on Drug Safety|January 12, 2016
DNA polymerase inhibitors for treating hepatitis B: a safety evaluationLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Gut and Liver|April 27, 2016
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionRan Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, et al.
Hepatology International|January 8, 2016
Prevention and management of hepatitis B virus reactivation in cancer patientsKa-Shing Cheung, Wai-Kay Seto, Ching-Lung Lai, et al.
Clinical and Molecular Hepatology|November 10, 2022
Correspondence on Letter regarding "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis"Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, et al.
Current Hepatitis Reports|December 2, 2011
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and SafetyYuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 15, 2017
Pharmacokinetic evaluation of besifovir for the treatment of HBV infectionLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Pageof 33